Astrazeneca

FromAstraZeneca ([email protected])
Subject (50)AstraZeneca to acquire TeneoTwo and T cell engager
Preheader (115)AstraZeneca to acquire TeneoTwo and its clinical-stage T-cell engager, strengthening haematological cancer pipeline
Typography
Arial
Colors
Text Analysis
Body Words194
Subject Words8
Body Emojis1
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images7
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px734 px
X-Spam Score0.3
Preheader OptimizedNo
Timing
Day of WeekWednesday
TimeEvening

AstraZeneca to acquire TeneoTwo and T cell engager

AstraZeneca to acquire TeneoTwo and its clinical-stage T-cell engager, strengthening haematological cancer pipeline
AstraZeneca to acquire TeneoTwo and T cell engager